Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Efficacy of osteoporosis therapies in a network meta-analysis with indirect comparisons: many concerns for new tools of evidence synthesis?

Catalá-López F, Sanfélix-Gimeno G, Tobías A, Hurtado I, Sanfélix-Genovés J, Peiró S.

Osteoporos Int. 2013 Jun;24(6):1927-8. doi: 10.1007/s00198-013-2294-9. Epub 2013 Feb 14. No abstract available.

PMID:
23408017
[PubMed - indexed for MEDLINE]
2.

Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis.

Freemantle N, Cooper C, Diez-Perez A, Gitlin M, Radcliffe H, Shepherd S, Roux C.

Osteoporos Int. 2013 Jan;24(1):209-17. doi: 10.1007/s00198-012-2068-9. Epub 2012 Jul 26.

PMID:
22832638
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Response to comments on: Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis.

Freemantle N, Cooper C, Diez-Perez A, Gitlin M, Radcliffe H, Shepherd S, Roux C.

Osteoporos Int. 2013 Jun;24(6):1931-2. doi: 10.1007/s00198-013-2299-4. Epub 2013 Feb 14. No abstract available.

PMID:
23408019
[PubMed - indexed for MEDLINE]
4.

Comment on Freemantle et al.: Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments.

Brandi ML, Reginster JY, Rizzoli R, Cannata-Andia JB.

Osteoporos Int. 2013 Jun;24(6):1929-30. doi: 10.1007/s00198-013-2297-6. Epub 2013 Feb 14. No abstract available.

PMID:
23408018
[PubMed - indexed for MEDLINE]
5.

Calcium supplementation in postmenopausal women to reduce the risk of osteoporotic fractures.

Spangler M, Phillips BB, Ross MB, Moores KG.

Am J Health Syst Pharm. 2011 Feb 15;68(4):309-18. doi: 10.2146/ajhp070175. Review.

PMID:
21289325
[PubMed - indexed for MEDLINE]
6.

Treating osteoporosis in Canada: what clinical efficacy data should be considered by policy decision makers?

Adachi JD, Kennedy CC, Papaioannou A, Ioannidis G, Leslie WD, Walker V.

Osteoporos Int. 2009 Oct;20(10):1785-93. doi: 10.1007/s00198-009-0870-9. Epub 2009 Mar 11.

PMID:
19277810
[PubMed - indexed for MEDLINE]
7.

Denosumab (prolia) for treatment of postmenopausal osteoporosis.

Johnson GL.

Am Fam Physician. 2012 Feb 15;85(4):334-6. Review. No abstract available.

PMID:
22335312
[PubMed - indexed for MEDLINE]
Free Article
8.

[Osteoporosis therapy. Drugs for strong bones].

[No authors listed]

MMW Fortschr Med. 2013 Nov 21;155(20):26. German. No abstract available.

PMID:
24482919
[PubMed - indexed for MEDLINE]
9.

My mother was saved from hip fracture by treatment for osteoporosis, but will I be?--Implications on risk estimates from successful osteoporosis treatment.

Rosengren BE, Karlsson MK.

Osteoporos Int. 2013 Feb;24(2):739. doi: 10.1007/s00198-012-2047-1. Epub 2012 Jun 16. No abstract available.

PMID:
22707066
[PubMed - indexed for MEDLINE]
10.

The efficacy of bisphosphonates in the prevention of vertebral, hip, and nonvertebral-nonhip fractures in osteoporosis: a network meta-analysis.

Jansen JP, Bergman GJ, Huels J, Olson M.

Semin Arthritis Rheum. 2011 Feb;40(4):275-84.e1-2. doi: 10.1016/j.semarthrit.2010.06.001. Epub 2010 Sep 9.

PMID:
20828791
[PubMed - indexed for MEDLINE]
11.

Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis.

Imaz I, Zegarra P, González-Enríquez J, Rubio B, Alcazar R, Amate JM.

Osteoporos Int. 2010 Nov;21(11):1943-51. doi: 10.1007/s00198-009-1134-4. Epub 2009 Dec 5. Review.

PMID:
19967338
[PubMed - indexed for MEDLINE]
12.

Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study.

Silverman SL, Chines AA, Kendler DL, Kung AW, Teglbjærg CS, Felsenberg D, Mairon N, Constantine GD, Adachi JD; Bazedoxifene Study Group.

Osteoporos Int. 2012 Jan;23(1):351-63. doi: 10.1007/s00198-011-1691-1. Epub 2011 Jul 21.

PMID:
21779819
[PubMed - indexed for MEDLINE]
13.

A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX(®).

Kanis JA, Johansson H, Oden A, McCloskey EV.

Osteoporos Int. 2011 Aug;22(8):2347-55. doi: 10.1007/s00198-010-1474-0. Epub 2011 Feb 2. Erratum in: Osteoporos Int. 2011 Aug;22(8):2357-8.

PMID:
21287148
[PubMed - indexed for MEDLINE]
14.

Bisphosphonates and osteoporotic fractures: a cross-design synthesis of results among compliant/persistent postmenopausal women in clinical practice versus randomized controlled trials.

Wilkes MM, Navickis RJ, Chan WW, Lewiecki EM.

Osteoporos Int. 2010 Apr;21(4):679-88. doi: 10.1007/s00198-009-0991-1. Epub 2009 Jul 2. Review.

PMID:
19572092
[PubMed - indexed for MEDLINE]
15.

Positive impact of compliance to strontium ranelate on the risk of nonvertebral osteoporotic fractures.

Rabenda V, Reginster JY.

Osteoporos Int. 2010 Dec;21(12):1993-2002. doi: 10.1007/s00198-009-1155-z. Epub 2010 Jan 16.

PMID:
20082066
[PubMed - indexed for MEDLINE]
16.

ACOG Practice Bulletin N. 129. Osteoporosis.

Committee on Practice Bulletins-Gynecology, The American College of Obstetricians and Gynecologists.

Obstet Gynecol. 2012 Sep;120(3):718-34. doi: 10.1097/AOG.0b013e31826dc446. No abstract available.

PMID:
22914492
[PubMed - indexed for MEDLINE]
17.

Real-world challenges of treating osteoporosis.

Owens G.

Am J Manag Care. 2011 May;17 Suppl 6:S177-84. Review.

PMID:
21882487
[PubMed - indexed for MEDLINE]
18.

Relationship between duration of compliant bisphosphonate use and the risk of osteoporotic fractures .

Meijer WM, Penning-van Beest FJ, Olson M, Herings RM.

Curr Med Res Opin. 2008 Nov;24(11):3217-22. doi: 10.1185/03007990802470241. Epub 2008 Oct 14.

PMID:
18922215
[PubMed - indexed for MEDLINE]
19.

Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis.

Meunier PJ, Roux C, Ortolani S, Diaz-Curiel M, Compston J, Marquis P, Cormier C, Isaia G, Badurski J, Wark JD, Collette J, Reginster JY.

Osteoporos Int. 2009 Oct;20(10):1663-73. doi: 10.1007/s00198-008-0825-6. Epub 2009 Jan 20.

PMID:
19153678
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Defining treatment failure in severe osteoporosis.

Confavreux CB, Paccou J, David C, Mehsen N, Leboime A, Thomas T.

Joint Bone Spine. 2010 Dec;77 Suppl 2:S128-32. doi: 10.1016/S1297-319X(10)70008-7.

PMID:
21211750
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk